These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31620444)

  • 1. MRI-Fusion Targeted vs. Systematic Prostate Biopsy-How Does the Biopsy Technique Affect Gleason Grade Concordance and Upgrading After Radical Prostatectomy?
    Rührup J; Preisser F; Theißen L; Wenzel M; Roos FC; Becker A; Kluth LA; Bodelle B; Köllermann J; Chun FKH; Mandel P
    Front Surg; 2019; 6():55. PubMed ID: 31620444
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy.
    Wenzel M; Preisser F; Wittler C; Hoeh B; Wild PJ; Tschäbunin A; Bodelle B; Würnschimmel C; Tilki D; Graefen M; Becker A; Karakiewicz PI; Chun FKH; Kluth LA; Köllermann J; Mandel P
    Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34063557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling.
    Luzzago S; Petralia G; Maresca D; Sabatini I; Cordima G; Brescia A; Verweij F; Garelli G; Mistretta FA; Cioffi A; Pricolo P; Alessi S; Ferro M; Matei DV; Renne G; de Cobelli O; Musi G
    Urol Oncol; 2020 Dec; 38(12):929.e11-929.e19. PubMed ID: 32600928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysis.
    Kesch C; Pantea V; Soeterik T; Marquis A; la Bombarda G; Morlacco A; Barletta F; Radtke JP; Darr C; Preisser F; Zattoni F; Marra G; van den Bergh RCN; Hadaschik B; Gandaglia G;
    World J Urol; 2023 Feb; 41(2):427-434. PubMed ID: 36534151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer detection with magnetic resonance imaging (MRI)/ cognitive fusion biopsy: Comparing standard and targeted prostate biopsy with final prostatectomy histology.
    Ryan J; Broe MP; Moran D; Mulvin D; Heffernan E; Swan N; Moran DE
    Can Urol Assoc J; 2021 Sep; 15(9):E483-E487. PubMed ID: 33591900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR; McNeal JE; Gill H; Presti JC
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging target fusion biopsy vs. transrectal ultrasound-guided biopsy - A comparative study of ISUP score upgrading risk in the final radical prostatectomy specimen.
    Guimarães T; Gil M; Medeiros M; Andrade V; Guerra J; Pinheiro H; Fernandes F; Pina J; Lopes Dias J; Campos Pinheiro L
    Arch Ital Urol Androl; 2022 Sep; 94(3):278-284. PubMed ID: 36165470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of TRUS and combined MRI-targeted plus systematic prostate biopsy for the concordance between biopsy and radical prostatectomy pathology.
    Aslan G; Çelik S; Sözen S; Akdoğan B; İzol V; Yücel Bilen C; Sahin B; Türkeri L;
    Int J Clin Pract; 2021 Mar; 75(3):e13797. PubMed ID: 33113261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy.
    Diamand R; Oderda M; Al Hajj Obeid W; Albisinni S; Van Velthoven R; Fasolis G; Simone G; Ferriero M; Roche JB; Piechaud T; Pastore A; Carbone A; Fiard G; Descotes JL; Marra G; Gontero P; Altobelli E; Papalia R; Kumar P; Eldred-Evans D; Giacobbe A; Muto G; Lacetera V; Beatrici V; Roumeguere T; Peltier A
    World J Urol; 2019 Oct; 37(10):2109-2117. PubMed ID: 30652213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized grade group for reporting prostate cancer grade in systematic and MRI-targeted biopsies.
    He Y; Shen Q; Fu W; Wang H; Song G
    Prostate; 2022 Aug; 82(11):1125-1132. PubMed ID: 35538399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
    Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
    Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine Learning-Based Prediction of Pathological Upgrade From Combined Transperineal Systematic and MRI-Targeted Prostate Biopsy to Final Pathology: A Multicenter Retrospective Study.
    Zhuang J; Kan Y; Wang Y; Marquis A; Qiu X; Oderda M; Huang H; Gatti M; Zhang F; Gontero P; Xu L; Calleris G; Fu Y; Zhang B; Marra G; Guo H
    Front Oncol; 2022; 12():785684. PubMed ID: 35463339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Systematic and MRI-US Fusion Prostate Biopsy Has the Highest Grading Accuracy When Compared to Final Pathology.
    Andras I; Cata ED; Serban A; Kadula P; Telecan T; Buzoianu M; Bungardean M; Stanca DV; Coman I; Crisan N
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34067302
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate magnetic resonance imaging-targeted biopsy global grade correlates better than highest grade with prostatectomy grade.
    Ren J; Melamed J; Taneja SS; Wysock JS; Huang WC; Lepor H; Deng FM
    Prostate; 2023 Mar; 83(4):323-330. PubMed ID: 36461793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative upgrading of prostate cancer in men ≥75 years: a propensity score-matched analysis.
    Herlemann A; Buchner A; Kretschmer A; Apfelbeck M; Stief CG; Gratzke C; Tritschler S
    World J Urol; 2017 Oct; 35(10):1517-1524. PubMed ID: 28493044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting pathological upgrading after prostatectomy in patients with Gleason grade group 1 prostate cancer based on opinion-matched biopsy specimens.
    Maruyama Y; Sadahira T; Araki M; Mitsui Y; Wada K; Rodrigo AGH; Munetomo K; Kobayashi Y; Watanabe M; Yanai H; Watanabe T; Nasu Y
    Mol Clin Oncol; 2020 Apr; 12(4):384-389. PubMed ID: 32190323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?
    Cheng X; Xu J; Chen Y; Liu Z; Sun G; Yang L; Yao J; Zeng H; Song B
    Front Oncol; 2021; 11():643051. PubMed ID: 33718240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative change in Gleason score of prostate cancer in fusion targeted biopsy: a matched pair analysis.
    Apfelbeck M; Tritschler S; Clevert DA; Buchner A; Chaloupka M; Kretschmer A; Herlemann A; Stief C; Schlenker B
    Scand J Urol; 2021 Feb; 55(1):27-32. PubMed ID: 33380254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Ipsilateral and Contralateral Transrectal Ultrasound-guided Systematic Prostate Biopsy in Men With Unilateral Magnetic Resonance Imaging Lesion Undergoing Magnetic Resonance Imaging-ultrasound Fusion-targeted Prostate Biopsy.
    Bryk DJ; Llukani E; Taneja SS; Rosenkrantz AB; Huang WC; Lepor H
    Urology; 2017 Apr; 102():178-182. PubMed ID: 27871829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.